Katie Eichinger

COO

Role
Chief Operating Officer at Duo Oncology
Location
Pittsburgh, PA, US
LinkedIn followers
500 followers

About Katie Eichinger

As the newest member of Duo Oncology, I will be spearheading efforts to conduct IND-enabling pre-clinical studies for our novel nanomaterial used to treat pancreatic and other difficult to treat cancers. Previously, I investigated infant immune responses to respiratory syncytial virus and performed pre-clinical studies of an investigational maternal RSV vaccine candidate. I most recently worked as a Research Scientist trying to understand the role of the transcription factor, NFATC2, in the development of hypersensitivity reactions to asparaginase treatment in pediatric patients afflicted with acute lymphoblastic leukemia.

Experience

  1. Chief Operating Officer

    Duo Oncology

    Sep 2024 — Present

Education

  • University of Michigan

    Doctor of Pharmacy (PharmD)

    2004 — 2009

  • University of Michigan

    Bachelor of Science (BS), Biology, General

    2000 — 2004

  • University of Pittsburgh

    PhD, Pharmaceutical Sciences

    2011 — 2019

  • University of Michigan

    Master of Clinical Research

    2007 — 2008

  • University of Pittsburgh

    Certificate in Clinical and Translational Science

    2011 — 2013

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Katie Eichinger — Chief Operating Officer at Duo Oncology in Pittsburgh, PA, US | Unifers